Maravai LifeSciences Holdings, Inc. Payments of Debt Issuance Costs
Maravai LifeSciences Holdings, Inc. (MRVI) reported Payments of Debt Issuance Costs of $3.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. payments of debt issuance costs for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. payments of debt issuance costs for the quarter ending 2020-12-31 was $9.04M.
- Maravai LifeSciences Holdings, Inc. payments of debt issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. payments of debt issuance costs for fiscal 2024 was $1.24M.
- Maravai LifeSciences Holdings, Inc. payments of debt issuance costs for fiscal 2023 was $0.00.
- Maravai LifeSciences Holdings, Inc. payments of debt issuance costs for fiscal 2022 was $0.00.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.58M 10-Q · filed 2026-08-07 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $1.24M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-18 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2020-12-31 | $9.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $9.29M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $250.00K 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |